Luxafimloc
Luxafimloc (GSK3882347) is a FimH inhibitor and anti-infective agent. Luxafimloc inhibits the activity of the FimH adhesin molecule. Luxafimloc reduces the bacterial load in the bladder of mice with acute cystitis induced by Klebsiella pneumoniae infection. Luxafimloc can be used in studies related to urinary tract infections, including cystitis, uncomplicated urinary tract infection, complicated urinary tract infection, catheter-associated urinary tract infection, acute urinary tract infection, recurrent urinary tract infection, and chronic urinary tract infection.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2408524-70-7
- Formule: C20H22F2O6
- Masse moléculaire:396.38
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C3H/HeN (female, 7-9 weeks old, specific pathogen free, transurethrally inoculated with Klebsiella pneumoniae strain TOP52, JMI-57, JMI-64, JMI-75, JMI-82, JMI-92)[1]
-
Dosage:50 mg/kg
-
Administration:s.c.; q12h; two doses
-
Result:Achieved a ≥2-Log10 drop in bladder bacterial CFU counts from pre-treatment baseline and vehicle control levels at 48 hours post initial infection.
Chemical Information
-
CAS No. 2408524-70-7
-
Masse moléculaire 396.38
-
Formule C20H22F2O6
-
SMILES
O[C@H](C1=C(C=C(C2=CC(F)=CC(F)=C2)C=C1)C)[C@@]3([H])O[C@@H]([C@H]([C@@H]([C@@H]3O)O)O)CO
-
Synonyms
GSK3882347
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)